Report for: Rethinking the “Pre” in Pre-Therapy Counseling: No Benefit of Additional Visits Prior to Therapy on Adherence or Viremia in Ugandans Initiating ARVs

Title	Rethinking the “Pre” in Pre-Therapy Counseling: No Benefit of Additional Visits Prior to Therapy on Adherence or Viremia in Ugandans Initiating ARVs
Published in	PLOS ONE, June 2012
DOI	10.1371/journal.pone.0039894
Pubmed ID	22761924
Authors	Mark J. Siedner, Alexander Lankowski, Jessica E. Haberer, Annet Kembabazi, Nneka Emenyonu, Alexander C. Tsai, Conrad Muzoora, Elvin Geng, Jeffrey N. Martin, David R. Bangsberg
Abstract	Many guidelines recommend adherence counseling prior to initiating antiretrovirals (ARVs), however the additional benefit of pre-therapy counseling visits on early adherence is not known. We sought to assess for a benefit of adherence counseling visits prior to ARV initiation versus adherence counseling during the early treatment period.

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.

Country	Count	As %
United States	1	100%

Type	Count	As %
Members of the public	1	100%

Mendeley readers

The data shown below were compiled from readership statistics for 79 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Country	Count	As %
United States	1	1%
Unknown	78	99%

Readers by professional status	Count	As %
Student > Master	17	22%
Researcher	13	16%
Student > Ph. D. Student	7	9%
Student > Bachelor	7	9%
Student > Doctoral Student	5	6%
Other	16	20%
Unknown	14	18%

Readers by discipline	Count	As %
Medicine and Dentistry	32	41%
Social Sciences	12	15%
Nursing and Health Professions	4	5%
Biochemistry, Genetics and Molecular Biology	3	4%
Business, Management and Accounting	3	4%
Other	10	13%
Unknown	15	19%

PLOS